Tivic Health Systems (TIVC) Competitors

$0.59
-0.75 (-55.97%)
(As of 05/9/2024 ET)

TIVC vs. NUWE, NDRA, HSDT, HSTO, PBLA, NBSE, LSDI, CANOQ, INM, and GRI

Should you be buying Tivic Health Systems stock or one of its competitors? The main competitors of Tivic Health Systems include Nuwellis (NUWE), ENDRA Life Sciences (NDRA), Helius Medical Technologies (HSDT), Histogen (HSTO), Panbela Therapeutics (PBLA), NeuBase Therapeutics (NBSE), Lucy Scientific Discovery (LSDI), Cano Health (CANOQ), InMed Pharmaceuticals (INM), and GRI Bio (GRI). These companies are all part of the "medical" sector.

Tivic Health Systems vs.

Nuwellis (NASDAQ:NUWE) and Tivic Health Systems (NASDAQ:TIVC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.

Nuwellis received 19 more outperform votes than Tivic Health Systems when rated by MarketBeat users.

CompanyUnderperformOutperform
NuwellisOutperform Votes
19
50.00%
Underperform Votes
19
50.00%
Tivic Health SystemsN/AN/A

3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 4.3% of Tivic Health Systems shares are owned by institutional investors. 0.9% of Nuwellis shares are owned by company insiders. Comparatively, 2.7% of Tivic Health Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Nuwellis has a net margin of -227.99% compared to Nuwellis' net margin of -701.02%. Nuwellis' return on equity of -186.19% beat Tivic Health Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Nuwellis-227.99% -218.79% -140.88%
Tivic Health Systems -701.02%-186.19%-138.20%

Tivic Health Systems has lower revenue, but higher earnings than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than Tivic Health Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuwellis$8.86M0.21-$20.21M-$13.46-0.02
Tivic Health Systems$1.18M0.74-$8.24M-$42.48-0.01

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nuwellis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tivic Health Systems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Nuwellis has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 2.83, meaning that its share price is 183% more volatile than the S&P 500.

In the previous week, Nuwellis had 6 more articles in the media than Tivic Health Systems. MarketBeat recorded 9 mentions for Nuwellis and 3 mentions for Tivic Health Systems. Nuwellis' average media sentiment score of 0.72 beat Tivic Health Systems' score of 0.28 indicating that Tivic Health Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nuwellis
1 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tivic Health Systems
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Tivic Health Systems beats Nuwellis on 9 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TIVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TIVC vs. The Competition

MetricTivic Health SystemsElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$865,000.00$3.26B$5.03B$7.79B
Dividend YieldN/A1.68%2.78%3.96%
P/E Ratio-0.0110.06167.2119.03
Price / Sales0.7460.252,376.0685.39
Price / CashN/A66.1233.7728.62
Price / Book0.243.975.334.62
Net Income-$8.24M$87.99M$105.46M$217.53M
7 Day Performance-44.87%0.46%0.52%1.43%
1 Month Performance-50.83%-8.61%-3.47%-2.23%
1 Year Performance-96.17%1.64%3.73%9.88%

Tivic Health Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUWE
Nuwellis
0 of 5 stars
$0.15
+6.9%
N/A-94.2%$1.05M$8.86M-0.0159Upcoming Earnings
News Coverage
Gap Up
NDRA
ENDRA Life Sciences
0 of 5 stars
$0.28
+7.6%
N/A-79.7%$3.12MN/A-0.1521Gap Up
HSDT
Helius Medical Technologies
2.7123 of 5 stars
$3.90
-4.6%
$54.50
+1,297.4%
-77.8%$3.47M$640,000.00-0.2726News Coverage
HSTO
Histogen
0 of 5 stars
$0.35
flat
N/A-75.8%$1.50M$3.77M-0.127
PBLA
Panbela Therapeutics
0.8007 of 5 stars
$0.43
-2.3%
$500.00
+116,179.1%
-99.9%$1.50MN/A0.006
NBSE
NeuBase Therapeutics
0 of 5 stars
$0.42
flat
N/A-89.2%$1.58MN/A-0.0537Positive News
LSDI
Lucy Scientific Discovery
0 of 5 stars
$0.83
+7.8%
N/A-94.1%$1.46M$10,000.00-0.122Positive News
CANOQ
Cano Health
0 of 5 stars
$0.30
+11.1%
N/AN/A$1.62M$3.14B0.002,700Gap Up
INM
InMed Pharmaceuticals
0 of 5 stars
$0.27
+12.6%
N/A-77.1%$1.63M$4.14M0.0013Negative News
Gap Up
GRI
GRI Bio
0 of 5 stars
0.43
-0.4%
N/A-99.2%$1.37MN/A-0.014Gap Up

Related Companies and Tools

This page (NASDAQ:TIVC) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners